Global and China Amifostine Market Insights, Forecast to 2027

Publisher Name :
Date: 10-Sep-2021
No. of pages: 138
Inquire Before Buying

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.

Global Amifostine key players include Sun Pharmaceutical, Clinigen Group, Merro Pharmaceutical, Taj Pharmaceuticals, Luye Pharma, etc. Global top five manufacturers hold a share over 90%. North America is the largest sales market, with a share over 50%, followed by Asia-Pacific with a share over 40 percent.

Market Analysis and Insights: Global and China Amifostine Market

This report focuses on global and China Amifostine market.

In 2020, the global Amifostine market size was US$ 49 million and it is expected to reach US$ 56 million by the end of 2027, with a CAGR of 2.1% during 2021-2027. In China the Amifostine market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Amifostine Scope and Market Size

Amifostine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Amifostine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For China market, this report focuses on the Amifostine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

- 400mg/Dose

- 500mg/Dose

Segment by Application

- Head and Neck Cancer Adjuvant Therapy

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Clinigen

- Sun Pharmaceutical

- Taj Pharmaceuticals

- Merro Pharmaceutical

- Luye Pharma

- Mingren Pharma

Global and China Amifostine Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Amifostine Product Introduction
1.2 Market by Type
1.2.1 Global Amifostine Market Size Growth Rate by Type
1.2.2 400mg/Dose
1.2.3 500mg/Dose
1.3 Market by Application
1.3.1 Global Amifostine Market Size Growth Rate by Application
1.3.2 Head and Neck Cancer Adjuvant Therapy
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Amifostine Market Size, Estimates and Forecasts
2.1.1 Global Amifostine Revenue 2016-2027
2.1.2 Global Amifostine Sales 2016-2027
2.2 Global Amifostine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Amifostine Historical Market Size by Region (2016-2021)
2.3.1 Global Amifostine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Amifostine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Amifostine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Amifostine Sales Forecast by Region (2022-2027)
2.4.2 Global Amifostine Revenue Forecast by Region (2022-2027)
3 Global Amifostine Competitor Landscape by Players
3.1 Global Top Amifostine Manufacturers by Sales
3.1.1 Global Amifostine Sales by Manufacturer (2016-2021)
3.1.2 Global Amifostine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Amifostine Manufacturers by Revenue
3.2.1 Key Amifostine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Amifostine Revenue by Manufacturers (2016-2021)
3.2.3 Global Amifostine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Amifostine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Amifostine Revenue in 2020
3.2.6 Global Amifostine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Amifostine Price by Manufacturers
3.4 Global Amifostine Manufacturing Base Distribution, Product Types
3.4.1 Amifostine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Amifostine Product Type
3.4.3 Date of International Manufacturers Enter into Amifostine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Amifostine Market Size by Type (2016-2021)
4.1.1 Global Amifostine Sales by Type (2016-2021)
4.1.2 Global Amifostine Revenue by Type (2016-2021)
4.1.3 Amifostine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Amifostine Market Size Forecast by Type (2022-2027)
4.2.1 Global Amifostine Sales Forecast by Type (2022-2027)
4.2.2 Global Amifostine Revenue Forecast by Type (2022-2027)
4.2.3 Amifostine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Amifostine Market Size by Application (2016-2021)
5.1.1 Global Amifostine Sales by Application (2016-2021)
5.1.2 Global Amifostine Revenue by Application (2016-2021)
5.1.3 Amifostine Price by Application (2016-2021)
5.2 Amifostine Market Size Forecast by Application (2022-2027)
5.2.1 Global Amifostine Sales Forecast by Application (2022-2027)
5.2.2 Global Amifostine Revenue Forecast by Application (2022-2027)
5.2.3 Global Amifostine Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Amifostine Market Size YoY Growth 2016-2027
6.1.1 China Amifostine Sales YoY Growth 2016-2027
6.1.2 China Amifostine Revenue YoY Growth 2016-2027
6.1.3 China Amifostine Market Share in Global Market 2016-2027
6.2 China Amifostine Market Size by Players (International and Local Players)
6.2.1 China Top Amifostine Players by Sales (2016-2021)
6.2.2 China Top Amifostine Players by Revenue (2016-2021)
6.3 China Amifostine Historic Market Review by Type (2016-2021)
6.3.1 China Amifostine Sales Market Share by Type (2016-2021)
6.3.2 China Amifostine Revenue Market Share by Type (2016-2021)
6.3.3 China Amifostine Price by Type (2016-2021)
6.4 China Amifostine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Amifostine Sales Forecast by Type (2022-2027)
6.4.2 China Amifostine Revenue Forecast by Type (2022-2027)
6.4.3 China Amifostine Price Forecast by Type (2022-2027)
6.5 China Amifostine Historic Market Review by Application (2016-2021)
6.5.1 China Amifostine Sales Market Share by Application (2016-2021)
6.5.2 China Amifostine Revenue Market Share by Application (2016-2021)
6.5.3 China Amifostine Price by Application (2016-2021)
6.6 China Amifostine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Amifostine Sales Forecast by Application (2022-2027)
6.6.2 China Amifostine Revenue Forecast by Application (2022-2027)
6.6.3 China Amifostine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Amifostine Market Size YoY Growth 2016-2027
7.2 North America Amifostine Market Facts & Figures by Country
7.2.1 North America Amifostine Sales by Country (2016-2021)
7.2.2 North America Amifostine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Amifostine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Amifostine Market Facts & Figures by Region
8.2.1 Asia Pacific Amifostine Sales by Region (2016-2021)
8.2.2 Asia Pacific Amifostine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Amifostine Market Size YoY Growth 2016-2027
9.2 Europe Amifostine Market Facts & Figures by Country
9.2.1 Europe Amifostine Sales by Country (2016-2021)
9.2.2 Europe Amifostine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Amifostine Market Size YoY Growth 2016-2027
10.2 Latin America Amifostine Market Facts & Figures by Country
10.2.1 Latin America Amifostine Sales by Country (2016-2021)
10.2.2 Latin America Amifostine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Amifostine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Amifostine Market Facts & Figures by Country
11.2.1 Middle East and Africa Amifostine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Amifostine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Clinigen
12.1.1 Clinigen Corporation Information
12.1.2 Clinigen Description and Business Overview
12.1.3 Clinigen Amifostine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Clinigen Amifostine Products Offered
12.1.5 Clinigen Recent Development
12.2 Sun Pharmaceutical
12.2.1 Sun Pharmaceutical Corporation Information
12.2.2 Sun Pharmaceutical Description and Business Overview
12.2.3 Sun Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sun Pharmaceutical Amifostine Products Offered
12.2.5 Sun Pharmaceutical Recent Development
12.3 Taj Pharmaceuticals
12.3.1 Taj Pharmaceuticals Corporation Information
12.3.2 Taj Pharmaceuticals Description and Business Overview
12.3.3 Taj Pharmaceuticals Amifostine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Taj Pharmaceuticals Amifostine Products Offered
12.3.5 Taj Pharmaceuticals Recent Development
12.4 Merro Pharmaceutical
12.4.1 Merro Pharmaceutical Corporation Information
12.4.2 Merro Pharmaceutical Description and Business Overview
12.4.3 Merro Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merro Pharmaceutical Amifostine Products Offered
12.4.5 Merro Pharmaceutical Recent Development
12.5 Luye Pharma
12.5.1 Luye Pharma Corporation Information
12.5.2 Luye Pharma Description and Business Overview
12.5.3 Luye Pharma Amifostine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Luye Pharma Amifostine Products Offered
12.5.5 Luye Pharma Recent Development
12.6 Mingren Pharma
12.6.1 Mingren Pharma Corporation Information
12.6.2 Mingren Pharma Description and Business Overview
12.6.3 Mingren Pharma Amifostine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Mingren Pharma Amifostine Products Offered
12.6.5 Mingren Pharma Recent Development
12.11 Clinigen
12.11.1 Clinigen Corporation Information
12.11.2 Clinigen Description and Business Overview
12.11.3 Clinigen Amifostine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Clinigen Amifostine Products Offered
12.11.5 Clinigen Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Amifostine Industry Trends
13.2 Amifostine Market Drivers
13.3 Amifostine Market Challenges
13.4 Amifostine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Amifostine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Amifostine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 400mg/Dose
Table 3. Major Manufacturers of 500mg/Dose
Table 4. Global Amifostine Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Amifostine Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Amifostine Sales by Regions (2016-2021) & (K Units)
Table 7. Global Amifostine Sales Market Share by Regions (2016-2021)
Table 8. Global Amifostine Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Amifostine Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Amifostine Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Amifostine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Amifostine Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Amifostine Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Amifostine Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Amifostine Manufacturers by Revenue (US$ Million) in 2020
Table 16. Amifostine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Amifostine Revenue Share by Manufacturers (2016-2021)
Table 18. Global Amifostine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Amifostine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amifostine as of 2020)
Table 20. Key Manufacturers Amifostine Price (2016-2021) (USD/Unit)
Table 21. Amifostine Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Amifostine Product Type
Table 23. Date of International Manufacturers Enter into Amifostine Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Amifostine Sales by Type (2016-2021) (K Units)
Table 26. Global Amifostine Sales Share by Type (2016-2021)
Table 27. Global Amifostine Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Amifostine Revenue Share by Type (2016-2021)
Table 29. Amifostine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 30. Global Amifostine Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Amifostine Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Amifostine Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Amifostine Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Amifostine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global Amifostine Sales by Application (2016-2021) (K Units)
Table 36. Global Amifostine Sales Share by Application (2016-2021)
Table 37. Global Amifostine Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Amifostine Revenue Share by Application (2016-2021)
Table 39. Amifostine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 40. Global Amifostine Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Amifostine Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Amifostine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Amifostine Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Amifostine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 45. China Amifostine Sales (K Units) of Key Companies (2016-2021)
Table 46. China Amifostine Sales Share by Company (2016-2021)
Table 47. China Amifostine Revenue (US$ Million) by Company (2016-2021)
Table 48. China Amifostine Revenue Share by Company (2016-2021)
Table 49. China Amifostine Sales (K Units) by Type (2016-2021)
Table 50. China Amifostine Sales Share by Type (2016-2021)
Table 51. China Amifostine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Amifostine Price (USD/Unit) by Type (2016-2021)
Table 53. China Amifostine Sales (K Units) by Type (2022-2027)
Table 54. China Amifostine Sales Share by Type (2022-2027)
Table 55. China Amifostine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Amifostine Revenue Share by Type (2022-2027)
Table 57. China Amifostine Price (USD/Unit) by Type (2022-2027)
Table 58. China Amifostine Sales (K Units) by Application (2016-2021)
Table 59. China Amifostine Sales Share by Application (2016-2021)
Table 60. China Amifostine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Amifostine Price (USD/Unit) by Application (2016-2021)
Table 62. China Amifostine Sales (K Units) by Application (2022-2027)
Table 63. China Amifostine Sales Share by Application (2022-2027)
Table 64. China Amifostine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Amifostine Revenue Share by Application (2022-2027)
Table 66. China Amifostine Price (USD/Unit) by Application (2022-2027)
Table 67. North America Amifostine Sales by Country (2016-2021) & (K Units)
Table 68. North America Amifostine Sales Market Share by Country (2016-2021)
Table 69. North America Amifostine Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Amifostine Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Amifostine Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Amifostine Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Amifostine Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Amifostine Revenue Market Share by Region (2016-2021)
Table 75. Europe Amifostine Sales by Country (2016-2021) & (K Units)
Table 76. Europe Amifostine Sales Market Share by Country (2016-2021)
Table 77. Europe Amifostine Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Amifostine Revenue Market Share by Country (2016-2021)
Table 79. Latin America Amifostine Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Amifostine Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Amifostine Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Amifostine Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Amifostine Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Amifostine Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Amifostine Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Amifostine Revenue Market Share by Country (2016-2021)
Table 87. Clinigen Corporation Information
Table 88. Clinigen Description and Business Overview
Table 89. Clinigen Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 90. Clinigen Amifostine Product
Table 91. Clinigen Recent Development
Table 92. Sun Pharmaceutical Corporation Information
Table 93. Sun Pharmaceutical Description and Business Overview
Table 94. Sun Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. Sun Pharmaceutical Product
Table 96. Sun Pharmaceutical Recent Development
Table 97. Taj Pharmaceuticals Corporation Information
Table 98. Taj Pharmaceuticals Description and Business Overview
Table 99. Taj Pharmaceuticals Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. Taj Pharmaceuticals Product
Table 101. Taj Pharmaceuticals Recent Development
Table 102. Merro Pharmaceutical Corporation Information
Table 103. Merro Pharmaceutical Description and Business Overview
Table 104. Merro Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. Merro Pharmaceutical Product
Table 106. Merro Pharmaceutical Recent Development
Table 107. Luye Pharma Corporation Information
Table 108. Luye Pharma Description and Business Overview
Table 109. Luye Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. Luye Pharma Product
Table 111. Luye Pharma Recent Development
Table 112. Mingren Pharma Corporation Information
Table 113. Mingren Pharma Description and Business Overview
Table 114. Mingren Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Mingren Pharma Product
Table 116. Mingren Pharma Recent Development
Table 117. Amifostine Market Trends
Table 118. Amifostine Market Drivers
Table 119. Amifostine Market Challenges
Table 120. Amifostine Market Restraints
Table 121. Amifostine Customers List
Table 122. Amifostine Distributors List
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Amifostine Product Picture
Figure 2. Global Amifostine Sales Market Share by Type in 2020 & 2027
Figure 3. 400mg/Dose Product Picture
Figure 4. 500mg/Dose Product Picture
Figure 5. Global Amifostine Sales Market Share by Application in 2020 & 2027
Figure 6. Head and Neck Cancer Adjuvant Therapy
Figure 7. Others
Figure 8. Amifostine Report Years Considered
Figure 9. Global Amifostine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Amifostine Market Size 2016-2027 (US$ Million)
Figure 11. Global Amifostine Sales 2016-2027 (K Units)
Figure 12. Global Amifostine Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Amifostine Sales Market Share by Region (2016-2021)
Figure 14. Global Amifostine Sales Market Share by Region in 2020
Figure 15. Global Amifostine Revenue Market Share by Region (2016-2021)
Figure 16. Global Amifostine Revenue Market Share by Region in 2020
Figure 17. Global Amifostine Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Amifostine Revenue in 2020
Figure 19. Amifostine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Amifostine Sales Market Share by Type (2016-2021)
Figure 21. Global Amifostine Sales Market Share by Type in 2020
Figure 22. Global Amifostine Revenue Market Share by Type (2016-2021)
Figure 23. Global Amifostine Revenue Market Share by Type in 2020
Figure 24. Global Amifostine Sales Market Share by Application (2016-2021)
Figure 25. Global Amifostine Sales Market Share by Application in 2020
Figure 26. Global Amifostine Revenue Market Share by Application (2016-2021)
Figure 27. Global Amifostine Revenue Market Share by Application in 2020
Figure 28. China Amifostine Sales Growth Rate 2016-2027 (K Units)
Figure 29. China Amifostine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. China Amifostine Market Share in Global Market 2016-2027
Figure 31. China 5 and 10 Largest Amifostine Players Market Share by Revenue in Amifostine in 2020
Figure 32. China Amifostine Revenue Share by Type (2016-2021)
Figure 33. China Amifostine Revenue Growth Rate by Type in 2016 & 2020
Figure 34. China Amifostine Revenue Share by Application (2016-2021)
Figure 35. China Amifostine Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Amifostine Sales Growth Rate 2016-2021 (K Units)
Figure 37. North America Amifostine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Amifostine Sales Market Share by Country in 2020
Figure 39. North America Amifostine Revenue Market Share by Country in 2020
Figure 40. U.S. Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 41. U.S. Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 43. Canada Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Amifostine Sales Growth Rate 2016-2021 (K Units)
Figure 45. Europe Amifostine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Amifostine Sales Market Share by Country in 2020
Figure 47. Europe Amifostine Revenue Market Share by Country in 2020
Figure 48. Germany Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 49. Germany Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 51. France Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 53. U.K. Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 55. Italy Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 57. Russia Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Amifostine Sales Growth Rate 2016-2021 (K Units)
Figure 59. Asia Pacific Amifostine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Amifostine Sales Market Share by Region in 2020
Figure 61. Asia Pacific Amifostine Revenue Market Share by Region in 2020
Figure 62. China Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 63. China Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 65. Japan Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 67. South Korea Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 69. India Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 71. Australia Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Taiwan Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 73. Taiwan Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 75. Indonesia Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 77. Thailand Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 79. Malaysia Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Philippines Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 81. Philippines Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Vietnam Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 83. Vietnam Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America Amifostine Sales Growth Rate 2016-2021 (K Units)
Figure 85. Latin America Amifostine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America Amifostine Sales Market Share by Country in 2020
Figure 87. Latin America Amifostine Revenue Market Share by Country in 2020
Figure 88. Mexico Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 89. Mexico Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Brazil Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 91. Brazil Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Argentina Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 93. Argentina Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Middle East and Africa Amifostine Sales Growth Rate 2016-2021 (K Units)
Figure 95. Middle East and Africa Amifostine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 96. Middle East and Africa Amifostine Sales Market Share by Country in 2020
Figure 97. Middle East and Africa Amifostine Revenue Market Share by Country in 2020
Figure 98. Turkey Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 99. Turkey Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Saudi Arabia Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 101. Saudi Arabia Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. U.A.E Amifostine Sales Growth Rate (2016-2021) (K Units)
Figure 103. U.A.E Amifostine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Amifostine Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed
  • Global and Japan Rhabdomyosarcoma Drug Market Insights, Forecast to 2027
    Published: 17-Sep-2021        Price: US 3900 Onwards        Pages: 156
    Rhabdomyosarcoma Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Rhabdomyosarcoma Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Rhabdomyosarc......
  • United States Hydroxycarbamide Market Report & Forecast 2021-2027
    Published: 16-Sep-2021        Price: US 3400 Onwards        Pages: 90
    United States Hydroxycarbamide Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Units) United States Hydroxycarbamide Market Segment Percentages, By Type, 2020 (%) - Capsule - Tablet United States Hydroxycarbamide Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Units) United States Hydroxycarbamide Market Segment Percentages, By Application, 2020 (%) - Sickle Cell Disease - Cancer - Others Compet......
  • United States Cyclophosphamide Market Report & Forecast 2021-2027
    Published: 13-Sep-2021        Price: US 3400 Onwards        Pages: 94
    United States Cyclophosphamide Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Person) United States Cyclophosphamide Market Segment Percentages, By Type, 2020 (%) - High-Dose - Low-Dose United States Cyclophosphamide Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Person) United States Cyclophosphamide Market Segment Percentages, By Application, 2020 (%) - Cancer - Autoimmune Diseases - AL Amyloidosis - Ot......
  • United States Cytotoxic Drug Market Report & Forecast 2021-2027
    Published: 13-Sep-2021        Price: US 3400 Onwards        Pages: 93
    United States Cytotoxic Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) United States Cytotoxic Drug Market Segment Percentages, By Type, 2020 (%) - Injection - Solid Oral Dose Forms - Others United States Cytotoxic Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) United States Cytotoxic Drug Market Segment Percentages, By Application, 2020 (%) - Breast Cancer - Blood Cancer - Prostate Cancer - Re......
  • United States Docetaxel Market Report & Forecast 2021-2027
    Published: 10-Sep-2021        Price: US 3400 Onwards        Pages: 93
    United States Docetaxel Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Docetaxel Market Segment Percentages, By Type, 2020 (%) - 20 mg/ml - 40 mg/ml - 60 mg/ml United States Docetaxel Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Docetaxel Market Segment Percentages, By Application, 2020 (%) - Breast Cancer - Prostate Cancer - Non-small Cell Lung Cancer......
  • Global and Japan Lentinan Market Insights, Forecast to 2027
    Published: 10-Sep-2021        Price: US 3900 Onwards        Pages: 138
    Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer. Panjin Gerun Biotech, Ajinomoto, Acetar Bio-Tech, Golden Horizon Biologics and Johncan Mushroom Bio-technology occupy the majority of lentinan market, among which Panjin Gerun Biotech had the largest market share of about 13% for production.The top five companies occupied about 62% share of the market. Health product fiel......
  • Global and China Cytotoxic Drug Market Size, Status and Forecast 2021-2027
    Published: 10-Sep-2021        Price: US 3900 Onwards        Pages: 108
    Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic' and ‘cytotoxic' are often used interchangeably. Cytotoxic drugs can ......
  • Global and China Amifostine Market Insights, Forecast to 2027
    Published: 10-Sep-2021        Price: US 3900 Onwards        Pages: 138
    Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol. Global Amifostine key players include Sun Pharmaceutical, Clinigen Group, Merro Pharmaceutical, Taj Pharmaceuticals, Luye Pharma, etc. Global top five manufacturers hold a share over 90%. North America is the largest sales market, with a share over 50%, followed by Asia-Pacific with a share ov......
  • Global and Japan Methotrexate Market Insights, Forecast to 2027
    Published: 10-Sep-2021        Price: US 3900 Onwards        Pages: 137
    Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection. Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis. North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs